Skip to Main Content

Paper Details

Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.
Cardiovasc Diabetol
0
2022
ACE2, ADAMTS13, COVID-19, CTSL1, Cardiometabolic comorbidities, IL, IL-1RA, IL6, KIM1, VEGFD, patient, patients, plasma
Author NameAffiliation
Philip SchroederMassachusetts General Hospital
Philip SchroederBroad Institute of MIT and Harvard
Philip SchroederCenter for Genomic Medicine, Massachusetts General Hospital
Varinderpal KaurMassachusetts General Hospital
Varinderpal KaurBroad Institute of MIT and Harvard
Varinderpal KaurCenter for Genomic Medicine, Massachusetts General Hospital
Edward T RyanMassachusetts General Hospital
Edward T RyanHarvard Medical School
Edward T RyanMassachusetts General Hospital
Edward T RyanHarvard T.H. Chan School of Public Health
James B MeigsMassachusetts General Hospital
James B MeigsHarvard Medical School
James B MeigsMassachusetts General Hospital
James B MeigsBroad Institute of MIT and Harvard
Jose C FlorezMassachusetts General Hospital
Jose C FlorezHarvard Medical School
Jose C FlorezMassachusetts General Hospital
Jose C FlorezBroad Institute of MIT and Harvard
Jose C FlorezCenter for Genomic Medicine, Massachusetts General Hospital
Richelle C CharlesMassachusetts General Hospital
Richelle C CharlesHarvard Medical School
Richelle C CharlesMassachusetts General Hospital
Richelle C CharlesHarvard T.H. Chan School of Public Health
Josep M MercaderMassachusetts General Hospital
Josep M MercaderCenter for Genomic Medicine, Massachusetts General Hospital
Josep M MercaderBroad Institute of MIT and Harvard
Josep M MercaderMassachusetts General Hospital
Josep M MercaderHarvard Medical School
Aaron LeongMassachusetts General Hospital
Aaron LeongCenter for Genomic Medicine, Massachusetts General Hospital
Aaron LeongBroad Institute of MIT and Harvard
Aaron LeongMassachusetts General Hospital
Aaron LeongHarvard Medical School
Aaron LeongMassachusetts General Hospital
  • 1 - 34

Datasets

Release 1.2